StockData
Dermata Therapeutics, Inc. logo

Dermata Therapeutics, Inc. (DRMA) stock

DRMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.53−0.01 (-1.50%)

Close on Nov 19, 2026Market cap $2.14MP/E –Yield –

Dermata Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Dermata Therapeutics

Dermata Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Dermata Therapeutics figures

See a number that looks wrong?